Cannabis Report
Home > Boards > US Listed > Biotechs >

Keryx Biopharmaceuticals, Inc (KERX)

KERX RSS Feed
Add KERX Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/21/2018 5:12:19 PM - Followers: 140 - Board type: Free - Posts Today: 0

 

 

 

Keryx Biopharmaceuticals is focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of life-threatening diseases, including cancer and renal disease. Keryx is developing KRX-0401 (perifosine), a novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway, and also affects a number of other key signal transduction pathways, including the JNK pathway, all of which are pathways associated with programmed cell death, cell growth, cell differentiation and cell survival. KRX-0401 has demonstrated both safety and clinical efficacy in several tumor types, both as a single agent and in combination with novel therapies. KRX-0401 is currently in Phase 3 clinical development for both multiple myeloma and refractory advanced colorectal cancer, and in Phase 2 clinical development for several other tumor types. Each of the KRX-0401 Phase 3 programs are being conducted under Special Protocol Assessment (SPA) agreements with the FDA. Keryx is also developing ZerenexTM (ferric citrate), an oral, iron-based compound that has the capacity to bind to phosphate and form non-absorbable complexes. The Phase 3 clinical program of ZerenexTM in the treatment for hyperphosphatemia (elevated phosphate levels) in patients with end-stage renal disease is pending commencement under an SPA agreement with the FDA. Keryx also actively engages in business development activities that include seeking strategic relationships for its product candidates, as well as evaluating compounds and companies for in-licensing or acquisition.

Keryx is headquartered in New York City.

Keryx Biopharmaceuticals is traded on the Nasdaq Stock Market under the symbol "KERX."





Corporate Headquarters

 

Keryx Biopharmaceuticals, Inc.
750 Lexington Ave. - 20th Floor
New York, NY 10022
Phone: 1-212-531-5965
Fax: 1-212-531-5961
Contact Email
Investor Relations IR@keryx.com
Business Development BusDev@keryx.com
Clinical Trials ClinicalTrials@keryx.com
Employment Opportunities

Company Website
jobs@keryx.com

http://www.keryx.com/



 

Product candidate Target indication Development status
     
ZerenexTM (ferric citrate) Hyperphosphatemia in patients with end-stage renal disease U.S. Phase 3 program ongoing under SPA; 
Japan Phase 3 program ongoing by sublicensee (JT and Torii)

 

Recent News:

http://ih.advfn.com/p.php?pid=news&symbol=N%5EKERX

http://www.otcmarkets.com/stock/KERX/news  

http://investors.keryx.com/phoenix.zhtml?c=122201&p=irol-news&nyo=0

Charts:

Gallery views:

http://stockcharts.com/freecharts/gallery.html?kerx


 

                KERX - Daily Candlesticks  


Analyst's estimates and ratings: 
http://investing.money.msn.com/investments/analyst-ratings/?symbol=kerx

http://www.marketwatch.com/investing/stock/KERX/analystestimates?subview=snapshot&pg=analyst

 

The most recent Quarterly (10-Q)
 
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=8450533

Do your own DD and trade smart.


 
 
  
Cannabis Report
KERX
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
KERX News: Current Report Filing (8-k) 07/20/2018 05:26:26 PM
KERX News: Statement of Changes in Beneficial Ownership (4) 07/19/2018 05:11:10 PM
KERX News: Statement of Changes in Beneficial Ownership (4) 07/12/2018 06:03:46 PM
KERX News: Statement of Changes in Beneficial Ownership (4) 07/12/2018 06:03:19 PM
KERX News: Statement of Changes in Beneficial Ownership (4) 07/12/2018 06:02:26 PM
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#3313   Michele, the following post was blocked. They block FredKerx 07/21/18 05:12:19 PM
#3312   The following, in my opinion, as always.. FredKerx 07/21/18 01:05:29 PM
#3311   @Michele Your post reads.. FredKerx 07/18/18 09:10:04 AM
#3308   One has to envision our legal teams going KarlDieGlatze 07/15/18 03:36:13 PM
#3307   UNABLE TO POST THE FOLLOWING ON YHOO BOARD, FredKerx 07/15/18 10:11:57 AM
#3306   From the Akebia website.. FredKerx 07/13/18 10:17:41 PM
#3305   THIS POST WAS BLOCKED ON THE YHOO BOARD. FredKerx 07/13/18 10:03:20 PM
#3304   Folks, the following my take, based on my FredKerx 07/13/18 09:59:48 AM
#3303   (The following post seemingly blocked on Yhoo board).. FredKerx 07/12/18 10:18:43 AM
#3302   psea 9 hours ago FredKerx 07/08/18 10:38:53 AM
#3301   KERX Board has absolutely neglected its fiduciary responsibilities Radtech 07/08/18 10:09:45 AM
#3300   Attempted to post this on Yahoo, but their PSea 07/07/18 05:26:04 PM
#3299   Folks, my posts on KERX Yhoo board are FredKerx 07/07/18 09:45:34 AM
#3298   Last night posted a series of posts related FredKerx 07/07/18 07:45:52 AM
#3297   It appears they took down the class action FredKerx 07/06/18 02:52:55 PM
#3296   In an important meeting. FredKerx 07/06/18 01:44:05 PM
#3295   For whatever reasons, Sanofi's stock(SNY) has been reacting KarlDieGlatze 07/06/18 11:46:28 AM
#3294   @Anfuhrermitwut Guidance withdrawal since Nov. 7, 2017 — FredKerx 07/06/18 10:37:29 AM
#3293   Lieber Fred, will you be our LEAD PLAINTIFF KarlDieGlatze 07/06/18 09:28:22 AM
#3292   (Could not post the following on Yhoo board, FredKerx 07/06/18 07:59:15 AM
#3291   Lieber Frederick, Please articulate the correct strategy excluding KarlDieGlatze 07/05/18 10:54:30 AM
#3290   (This post also seemingly blocked on Yhoo board) FredKerx 07/04/18 06:39:51 PM
#3289   (Note: This post was blocked from publishing on FredKerx 07/04/18 04:17:51 PM
#3288   If SNY was being pushed out by Dem KarlDieGlatze 07/03/18 11:45:02 PM
#3287   Lieber Frederick, Make note of the ATM "Cantor KarlDieGlatze 07/03/18 04:25:14 PM
#3286   10Q expanded data surrounding License Agreement with Vifor: KarlDieGlatze 07/03/18 04:22:36 PM
#3285   Lieber Frederick, the termination terms you require as KarlDieGlatze 07/03/18 04:11:48 PM
#3284   Liebe Frederick, they are deleting so many of KarlDieGlatze 07/03/18 11:36:45 AM
#3283   If I were a lawyer while excluding the KarlDieGlatze 07/03/18 11:32:44 AM
#3282   Liebe Frederick, in case they DELETE my Yahoo KarlDieGlatze 07/03/18 10:43:11 AM
#3281   Liebe Frederick, what did you think about the KarlDieGlatze 07/03/18 09:42:02 AM
#3280   MY POSTS ARE BEING BLOCKED AGAIN! FredKerx 07/02/18 10:16:48 AM
#3279   And, those 4 million stolen shares on the KarlDieGlatze 07/01/18 03:03:02 PM
#3278   Liebe Fred, Is "that klarman guy" hitting the KarlDieGlatze 07/01/18 02:48:46 PM
#3277   Think some are shortsighted and don’t realize extent FredKerx 07/01/18 08:50:17 AM
#3276   what am i missing here? sardic420 06/30/18 09:39:55 AM
#3275   Poster Dick writes in his last post on FredKerx 06/30/18 07:34:38 AM
#3274   I do not see anything good about the dwighttl 06/29/18 11:00:02 AM
#3273   Folks, with merger, AKBA outstanding goes from 57 FredKerx 06/29/18 10:40:06 AM
#3272   You are overlooking the fact that the shares fsulevine 06/28/18 11:23:15 PM
#3271   Fellow shareholders, the merger is reducing our KERX FredKerx 06/28/18 08:22:52 PM
#3270   Fellow shareholders, the merger is reducing our KERX FredKerx 06/28/18 08:08:49 PM
#3269   KERX has spent some $550 million over 41/2 FredKerx 06/28/18 07:38:31 PM
#3268   @X What makes you think KERX’s future is FredKerx 06/28/18 06:27:31 PM
#3267   I knew a merger was the machination to FredKerx 06/28/18 03:47:05 PM
#3266   Bottom line, it’s AKBA pps looking forward that FredKerx 06/28/18 03:36:04 PM
#3265   If my calculations are accurate, KERX shareholders will FredKerx 06/28/18 03:02:18 PM
#3264   If the Ihub post below is accurate, KERX FredKerx 06/28/18 02:40:44 PM
#3263   If you own 10,000 shares of KERX, pos FredKerx 06/28/18 02:24:41 PM
#3262   Why such a strong negative reaction on the fsulevine 06/28/18 12:49:24 PM
PostSubject